LIPOPOLYSACCHARIDE-INDUCED SICKNESS BEHAVIOR IN PIGS IS INHIBITED BY PRETREATMENT WITH INDOMETHACIN

被引:136
作者
JOHNSON, RW [1 ]
VON BORELL, E [1 ]
机构
[1] IOWA STATE UNIV SCI & TECHNOL, DEPT ANIM SCI, AMES, IA 50011 USA
关键词
PIGS; BEHAVIOR; INDOMETHACIN; LIPOPOLYSACCHARIDE; PROSTAGLANDINS;
D O I
10.2527/1994.722309x
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Many of the behavioral responses following acute bacterial or viral infection are now considered important for maintaining homeostasis during inflammation. In the present study, we extend this concept to pigs (16 crossbred barrows) by demonstrating that lipopolysaccharide (LPS, .5, 5, or 50 mu g/kg BW) from Escherichia coli injected i.p. reduces feed intake, decreases activity, and elevates body temperature. To determine whether any of these effects could be mediated via a prostaglandin (PG)dependent mechanism, a second experiment with 16 crossbred barrows was conducted. Barrows were pretreated with indomethacin (IND, 5 mg/kg BW [a cyclooxygenase inhibitor]), and their behavior and body temperature following a challenge i.p. injection of LPS (5 mu g/kg BW) were assessed. Pretreatment with IND inhibited the anorexia and inactivity caused by LPS, suggesting that the behavioral effects of LPS are dependent on activation of a PG system. Lipopolysaccharide alone, however, did not elevate body temperature in this case; thus, the involvement of PGs in this response was not determined. Collectively, these data indicate that pigs respond to LPS by reducing feed intake, decreasing activity, and becoming febrile. The ability of IND to inhibit behavioral effects of LPS is consistent with the hypothesis that a PG system is involved in mediating sickness behavior. Perhaps, by altering the activity of cyclooxygenase it is possible to enhance or inhibit the behavioral symptoms of sickness in pigs.
引用
收藏
页码:309 / 314
页数:6
相关论文
共 50 条
  • [1] The taste of sickness: Lipopolysaccharide-induced finickiness in rats
    Aubert, A
    Dantzer, R
    PHYSIOLOGY & BEHAVIOR, 2005, 84 (03) : 437 - 444
  • [2] Microglial Ultrastructure in the Hippocampus of a Lipopolysaccharide-Induced Sickness Mouse Model
    Savage, Julie C.
    St-Pierre, Marie-Kim
    Hui, Chin Wai
    Tremblay, Marie-Eve
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [3] LIPOPOLYSACCHARIDE-INDUCED HEPATOTOXICITY IS INHIBITED BY THE ANTIOXIDANT MELATONIN
    SEWERYNEK, E
    MELCHIORRI, D
    REITER, RJ
    ORTIZ, GG
    LEWINSKI, A
    EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 293 (04): : 327 - 334
  • [4] CCK2 receptor nullification attenuates lipopolysaccharide-induced sickness behavior
    Weiland, Tracey J.
    Voudouris, Nicholas J.
    Kent, Stephen
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 292 (01) : R112 - R123
  • [5] Temporal Analysis of Lipopolysaccharide-Induced Sickness Behavior in Virgin and Lactating Female Rats
    Nascimento, Amanda
    Bernardi, Maria
    Pecorari, Vanessa
    Massoco, Christina
    Felicio, Luciano
    NEUROIMMUNOMODULATION, 2013, 20 (06) : 305 - 312
  • [6] Indomethacin augments lipopolysaccharide-induced expression of inflammatory molecules in the mouse brain
    Mohamed, Mona Yasin
    Masocha, Willias
    PEERJ, 2020, 8
  • [7] The effects of captopril on lipopolysaccharide-induced sickness behaviors in rats
    Abareshi, Azam
    Anaeigoudari, Akbar
    Norouzi, Fatemeh
    Marefati, Narges
    Beheshti, Farimah
    Saeedjalali, Mohsen
    Hosseini, Mahmoud
    VETERINARY RESEARCH FORUM, 2019, 10 (03) : 199 - 205
  • [8] Lipopolysaccharide-induced sickness behavior is not altered in male Fmr1-deficient mice
    Santana-Coelho, Danielle
    Hodges, Samantha L.
    Quintero, Saul I.
    Womble, Paige D.
    Sullens, D. Greg
    Narvaiz, David A.
    Herrera, Rebecca
    Sekeres, Melanie J.
    Lugo, Joaquin N.
    BRAIN AND BEHAVIOR, 2023,
  • [9] Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat
    Mathias, S
    Schiffelholz, T
    Linthorst, ACE
    Pollmächer, T
    Lancel, M
    NEUROENDOCRINOLOGY, 2000, 71 (06) : 375 - 385
  • [10] Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain
    Tito, Pedro Augusto Lopes
    Bernardino, Tulio Cezar de Souza
    Bellozi, Paula Maria Quaglio
    da Silva, Maria Carolina Machado
    de Miranda, Aline Silva
    Vieira, Erica Leandro Marciano
    Moreira, Fabricio A.
    Palotas, Andras
    de Oliveira, Antonio Carlos Pinheiro
    Reis, Helton Jose
    PHARMACOLOGICAL REPORTS, 2021, 73 (06) : 1680 - 1693